NuVim, Inc.
NUVM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -34.5% | 140.2% | -23.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,361.8% | -1,165.2% | -1,993.5% | -1,755% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,403.3% | -1,192.2% | -2,058.8% | -1,804.8% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 0% | 0% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |